Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01802034 · ClinicalTrials.gov registry record

Repository of Novel Analytes Leading to Autoimmune, Inflammatory and Diabetic Nephropathies (RENAL AID)

A clinical trial of Kidney Diseases and Lupus Nephritis, sponsored by The Rogosin Institute.

Recruiting
Registry status
2,000
Enrollment target
1
Study location

NCT01802034 is a study of Kidney Diseases and Lupus Nephritis that is actively recruiting participants, run by The Rogosin Institute. The registered enrollment target is 2,000 participants, above the 1,733-participant average among 38 other Kidney Diseases trials with a reported enrollment target (15% higher). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01802034, a study of Kidney Diseases and Lupus Nephritis, is actively recruiting participants, sponsored by The Rogosin Institute.

RECRUITING
Registry status
2,000 participants
Enrollment target
1
Study location

Study Summary

A central goal of this data repository is to collect data from a large population of subjects with a variety of renal disease states. Cohorts will include subjects with diabetes, inflammatory/autoimmune and transplant related renal conditions. Additionally, the repository will have the capacity to store biospecimens and electronic data in control subjects without established renal disease. This initiative will provide an opportunity to compare data from various disease states and controls with the objective of determining clinical and biological factors that predict disease progression, response to therapy and identify discriminating noninvasive clinical and biological features that predict renal biopsy findings.

Study Locations (1)

New York

  • The Rogosin Institute - New York

Trial Details

FieldValue
Enrollment Target 2,000 participants
Start Date 2013-02
Est. Completion 2028-08

Sponsor

The Rogosin Institute

21 total trials

What the Registry Record Tells You About NCT01802034

The ClinicalTrials.gov registry entry for NCT01802034 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 2,000 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 1,733-participant average among 38 other Kidney Diseases trials with a reported enrollment target (15% higher). The listed sponsor is The Rogosin Institute, which has 21 total studies on file at ClinicalTrials.gov.

The record links to 5 conditions, with Kidney Diseases appearing as the primary indexed condition, and to 0 interventions.

NCT01802034 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.

Frequently Asked Questions

What is clinical trial NCT01802034 about?

NCT01802034 is a clinical study titled "Repository of Novel Analytes Leading to Autoimmune, Inflammatory and Diabetic Nephropathies (RENAL AID)". A central goal of this data repository is to collect data from a large population of subjects with a variety of renal disease states. Cohorts will include subjects with diabetes, inflammatory/autoimmune and transplant related renal conditions. Additionally, the repository will have the capacity to s...

What is the current status of trial NCT01802034?

This trial is currently recruiting. The enrollment target is 2,000 participants. The study started on 2013-02. Estimated completion is 2028-08.

What conditions does trial NCT01802034 study?

This clinical trial studies the following conditions: Kidney Diseases, Lupus Nephritis, Kidney Failure, Chronic, Diabetic Nephropathy, Glomerulonephritis, IGA.

Who is sponsoring clinical trial NCT01802034?

This trial is sponsored by The Rogosin Institute, which has 21 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01802034 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Kidney Diseases

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.